| Literature DB >> 35075998 |
Constentin Dieme, Kiet A Ngo, Shaun Tyler, Joseph G Maffei, Steven D Zink, Alan P Dupuis, Cheri A Koetzner, Chelsea Shultis, Jessica Stout, Anne F Payne, P Bryon Backenson, Lili Kuo, Michael A Drebot, Alexander T Ciota, Laura D Kramer.
Abstract
Cache Valley virus (CVV) is a mosquitoborne virus that infects livestock and humans. We report results of surveillance for CVV in New York, USA, during 2000-2016; full-genome analysis of selected CVV isolates from sheep, horse, humans, and mosquitoes from New York and Canada; and phenotypic characterization of selected strains. We calculated infection rates by using the maximum-likelihood estimation method by year, region, month, and mosquito species. The highest maximum-likelihood estimations were for Anopheles spp. mosquitoes. Our phylogenetic analysis identified 2 lineages and found evidence of segment reassortment. Furthermore, our data suggest displacement of CVV lineage 1 by lineage 2 in New York and Canada. Finally, we showed increased vector competence of An. quadrimaculatus mosquitoes for lineage 2 strains of CVV compared with lineage 1 strains.Entities:
Keywords: Anopheles punctipennis; Anopheles quadrimaculatus; Cache Valley virus; New York; United States; lineage displacement; mosquitoes; surveillance; vector competence; vector-borne infections; viruses; zoonoses
Mesh:
Year: 2022 PMID: 35075998 PMCID: PMC8798675 DOI: 10.3201/eid2802.203810
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Figure 1Counties in New York, USA, in which Cache Valley virus was studied during 2000‒2016 (https://www.health.ny.gov/statistics/cancer/registry/images/nycounty). Asterisks (*) indicate counties in which samples positive for Cache Valley virus were collected. NA, counties not included in data; NT, counties not tested for Cache Valley virus.
Sequences of primers and probes used for detection of CVV, New York, USA*
| Name | Sequence, 5′ → 3′ | Primer/probe |
|---|---|---|
| CVVF1 | ACAGCCAATGGTGTCGAAAAC | Primer |
| CVVR1 | TGCAGGGATGCTAGACAAGATG | Primer |
| CVV1Probe | 6FAM-CTGACGGTATTGAATCAGCAT-MGBNFQ | Probe |
| CVVF2 | GGTGCCACATAAAGAAAACTG | Primer |
| CVVR2 | GCCAAGCAACCAAACTC | Primer |
| CVV-1-R | TGATGGCCAAACAACCAA AT | Primer |
| CVV-1-F | GTGCCACATAAAGAGAACTGGATG | Primer |
| CVV2Probe | 56FAM-CACCCCCATCTGCTTGTTCTTTCCTGAGAG-3IBkFQ | Probe |
*CVV, Cache Valley virus.
Primers used for Sanger sequencing of CVV, New York, USA*
| Primer | Sequence, 5′ → 3′ | Target |
|---|---|---|
| CVVM | AGTAGTGTGCTACCGATA | M segment |
| CVVMR5 | ACTCCTGCCTGCCAGAGTGC | 1–2239 bp |
| CVVMF4 | AATGCATTCCCAGGAACAAC | M segment |
| CVVMR2 | CCTCTAGAGTCTCATGATTA | 1984–3725 bp |
| CVVMF6 | ATCCCTGCATTAGGTGGAAT | M segment |
| CVVM | AGTAGTGTGCTACCGATA | 2981–4464 bp |
| CVVrtL | CTGACCATACCCGAGAGGCTAGTAGTGTACTCCT | L segment |
| NLR10 | CTGTTGCTCTTTTTGTCTTGATGTCTGAAG | 1–1717 bp |
| LF3 | GGGGGTATTCTCAGACCAGA | L segment |
| NLR7 | GGATCTAAAACTATAAGCCAAAAATACTT | 1482–3221 bp |
| NLF6 | CTAAAGAAAGATGTAAGTTAAATACAGATG | L segment |
| LR4 | CATCAGTGGGTCATTTAATA | 2984–4722 bp |
| NLF8 | ATATCAATGCGCCATTATACCTTATATC | L segment |
| LR2 | CTGACATAAATTCGAACTTC | 3986–5722 bp |
| LF11b | ACAAATTCGATGCTCTAAAAACAA | L segment |
| CVVrtL | CTGACCATACCCGAGAGGCTAGTAGTGTACTCCT | 5474–6871 bp |
| CVVrtALL | CTGACCATACCCGAGAGGCTAGTGTGTACT | S segment |
| CVVs | AGTAGTGTGCTCCAC | 1–922 bp |
*CVV, Cache Valley virus; L, large; M, medium; S, small.
Figure 2Cache Valley virus infection rate, New York, USA, during 2000‒2016, calculated by using MLE, by year (A), mosquito species (B), New York regions (C), and combined mosquito species and years (D). Error bars indicate upper and lower limits of infection rate based on 95% confidence levels. Numbers next to bars indicate number of pools tested. MLEs were calculated by using a Centers for Disease Control and Prevention resource (https://www.cdc.gov/westnile/resourcepages/mosqsurvsoft.html). *p<0.05 by χ2 test. CIN, Ae. cinereus; MLE, maximum-likelihood estimation; PUN, An. punctipennis; QUA, An. quadrimaculatus; SOL, Ae. sollictans; TVT, Ae. trivittatus.
Characteristics for Cache Valley virus strains, New York, USA, and Ontario, Canada, 2000‒2016
| Year | Mosquito species | County | Strain | Lineage |
|---|---|---|---|---|
| 2001 |
| Saratoga | NY1 | Lineage 1 |
| 2001 |
| Dutchess | NY15 | Lineage 1 |
| 2001 |
| Ulster | NY16 | Lineage 1 |
| 2001 |
| Saratoga | NY17 | Lineage 1 |
| 2003 |
| Onondaga | NY2 | Lineage 1 |
| 2003 |
| Oswego | NY3 | Lineage 1 |
| 2003 |
| Suffolk | NY4 | Lineage 1 |
| 2003 |
| Orange | NY5 | Lineage 1 |
| 2003 |
| Westchester | NY6 | Lineage 1 |
| 2003 |
| Westchester | NY7 | Lineage 1 |
| 2003 |
| Erie | NY8 | Lineage 1 |
| 2003 |
| Columbia | NY9 | Lineage 1 |
| 2003 |
| Dutchess | NY10 | Lineage 1 |
| 2003 |
| Orange | NY11 | Lineage 1 |
| 2003 |
| Westchester | NY12 | Lineage 1 |
| 2003 |
| Westchester | NY13 | Lineage 1 |
| 2003 |
| Orange | NY14 | Lineage 1 |
| 2003 |
| Erie | NY18 | Lineage 1 |
| 2003 |
| Madison | NY19 | Lineage 1 |
| 2003 |
| Orange | NY20 | Lineage 1 |
| 2003 |
| Dutchess | NY21 | Lineage 1 |
| 2003 |
| Suffolk | NY22 | Lineage 1 |
| 2003 |
| Putnam | NY23 | Lineage 1 |
| 2004 |
| Orange | NY24 | Lineage 1 |
| 2005 |
| Erie | NY25 | Lineage 1 |
| 2005 |
| Monroe | NY26 | Lineage 1 |
| 2005 |
| Lewis | NY27 | Lineage 1 |
| 2006 |
| Chautauqua | 6048 | Lineage 1 |
| 2006 |
| Chautauqua | 6065 | Lineage 1 |
| 2006 |
| Chautauqua | 6066 | Lineage 1 |
| 2006 |
| Chautauqua | 6078 | Lineage 1 |
| 2006 |
| Chautauqua | 6194 | Lineage 1 |
| 2006 |
| Wayne | 58027 | Lineage 1 |
| 2007 |
| Madison | 26119 | Lineage 1 |
| 2011 | Horse | Cattaraugus | R11–5096 | Lineage 1 |
| 2011 | Human | Unknown | Hu-2011 | Lineage 2 |
| 2012 | Sheep | Ontario | cvv_placenta | Lineage 2 |
| 2012 |
| Ontario | OT4651 | Lineage 2 |
| 2012 |
| Ontario | OT4688 | Lineage 2 |
| 2015 |
| Orange | 15350152 | Lineage 2 |
| 2015 |
| Oswego | 15370591 | Lineage 2 |
| 2015 |
| Onondaga | 15330577 | Lineage 2 |
| 2015 |
| Oswego | 15370479 | Lineage 2 |
| 2015 |
| Oswego | 15370500 | Lineage 2 |
| 2015 |
| Oswego | 15370522 | Lineage 2 |
| 2015 |
| Oswego | 15370514 | Lineage 2 |
| 2015 |
| Oswego | 15370550 | Lineage 2 |
| 2015 |
| Cattaraugus | 15041170 | Reassortant |
| 2015 |
| Chatauqua | 15060131 | Reassortant |
| 2015 |
| Cattaraugus | 15041084 | Reassortant |
| 2016 | Human | Allegany | PA | Reassortant |
Figure 3Phylogenetic analysis of Cache Valley virus, New York, USA, 2000‒2016. Maximum-likelihood phylogenetic trees show complete nucleotide sequences of small (A), medium (B), and large (C) genome segments. Numbers at nodes indicate boostrap support estimated by using 500 neighbor-joining replicates. Trees were rooted to Fort Sherman virus small, medium, and large genome segments (GenBank accessions nos. KX100130, KX100131, and KX100132). Scale bars indicate nucleotide substitutions per site.
Mean genetic distances for 3 genomic segments of 2 lineages of Cache Valley virus, New York, USA, 2000‒2016
| Lineage | Intralineage (interlineage) | ||
|---|---|---|---|
| Small | Medium | Large | |
| 1 | 0.0046 (0.040) | 0.0109 (0.074) | 0.0062 (0.051) |
| 2 | 0.0023 (0.040) | 0.0033 (0.074) | 0.0278 (0.051) |
Relationship between dose and competence of Anopheles quadrimaculatus mosquitoes for Cache Valley virus, New York, USA, 2000‒2016*
| Strain | Day postinfection | Blood meal titer log10 PFU/mL | No. infected/no. tested (%) | No. disseminated/no. tested (%) | No. transmitted.no. tested (%) |
|---|---|---|---|---|---|
| L1-NY10 | 15 | 5.1 | 11 /25 (44) | 10/11 (90.91) | 0/10 (0) |
| 4.2 | 3/25 (12)† | 2/3 (66.67) | 0/2 (0) | ||
|
|
| 3 | 0/25 (0) | NT | NT |
| L1-NY25 | 15 | 6.8 | 24/25 (96) | 22/24 (91.67) | 1/22 (4.55) |
| 5.7 | 13/25 (52) | 12/13 (92.31) | 1/12 (8.33) | ||
|
|
| 4.5 | 3/25 (12)† | 0/3 (0)‡ | NT |
| L2–15350152 | 15 | 5.1 | 18/25 (72) | 18/18 (100) | 0/18 (0) |
| 4.3 | 16/25 (64) | 16/16 (100) | 2/16 (12.50) | ||
|
|
| 3 | 7/25 (28) | 7/7 (100) | 1/7 (14.29) |
| L2–15330577 | 15 | 5.7 | 19/25 (76) | 19/19 (100) | 8/19 (42.11) |
| 5 | 15/25 (60) | 15/15 (100) | 7/15 (46.67) | ||
|
|
| 3.7 | 7/25 (28) | 7/7 (100) | 2/7 (28.57) |
| R-15041084 | 15 | 5.3 | 15/25 (60) | 15/15 (100) | 1/15 (6.67) |
| 4.4 | 13/25 (52) | 13/13 (100) | 1/13 (7.69) | ||
|
|
| 3.2 | 5/25 (20) | 3/5 (60) | 0/3 (0) |
| R-PA | 15 | 4.9 | 10/25 (40) | 0/10 (0) | NT |
| 3.7 | 6/25 (24) | 0/6 (0) | NT | ||
| 2.9 | 0/25 (0) | NT | NT |
*L1, lineage 1; L2, lineage 2; NT, not tested; R, reassortant (containing lineage 1 large RNA segment and lineage 2 small and medium RNA segments); NT, not tested. †p<0.05: lineage 1 strain infection rate compared with lineage 2 (15350152) strain when mosquitoes were fed on infectious blood ≈4–4.5 log10 PFU/mL titer. ‡p<0.05: lineage 1 strains dissemination rate compared with lineage 2 strains when mosquitoes were fed on infectious blood ≈4–4.5 log10 PFU/mL titer.
Infection, dissemination, and transmission rates for Anopheles quadrimaculatus mosquitoes for different Cache Valley virus isolates, New York, USA, 2000‒2016*
| Strain | Blood meal titer, log10 PFU/mL | Day postinfection | No. infected/no. tested (%) | No. disseminated/no. tested (%) | No. transmitted/no. tested (%) |
|---|---|---|---|---|---|
| L1-NY10 | 7.1 | 2 | 25/25 (100) | 18/25 (72)† | NT |
| 6 | 42/42 (100) | 42/42 (100) | 5/42 (11.90) | ||
|
|
| 15 | 41/41 (100) | 41/41 (100) | 5/41 (12.20) |
| L1-NY25 | 6.6 | 2 | 18/25 (72)‡ | 3/18 (16.67)† | NT |
| 6 | 31/35 (88.57)‡ | 16/31 (51.61)† | 0/16 (0) | ||
|
|
| 15 | 32/35 (91.43)‡ | 23/32 (71.88)† | 4/23 (17.39) |
| L2–15350152 | 7.2 | 2 | 25/25 (100) | 25/25 (100) | NT |
| 6 | 37/37 (100) | 37/37 (100) | 11/37 (29.73) | ||
|
|
| 15 | 44/44 (100) | 44/44 (100) | 24/44 (54.54) |
| L2–15330577 | 7.1 | 2 | 25/25 (100) | 25/25 (100) | NT |
| 6 | 35/35 (100) | 35/35 (100) | 7/35 (20) | ||
|
|
| 15 | 35/35 (100) | 35/35 (100) | 10/35 (28.57) |
| L2-Hu2011 | 6.3 | 2 | 25/25 (100) | 25/25 (100) | NT |
| 6 | 30/30 (100) | 30/30 (100) | 8/30 (26.67) | ||
| 15 | 30/30 (100) | 30/30 (100) | 9/30 (30) | ||
| 5.5 | 2 | 25/25 (100) | 25/25 (100) | NT | |
| 6 | 30/30 (100) | 30/30 (100) | 1/30 (3.33) | ||
|
|
| 15 | 24/24 (100) | 24/24 (100) | 5/24 (20.83) |
| R-15041084 | 7.1 | 2 | 25/25 (100) | 25/25 (100) | NT |
| 6 | 41/41 (100) | 41/41 (100) | 6/41 (14.63) | ||
|
|
| 15 | 34/34 (100) | 34/34 (100) | 18/34 (52.94) |
| R-PA | 5 | 2 | 10/25 (40) | 4/10 (40) | NT |
| 6 | 21/35 (60) | 3/21 (14.29) | 0/3 (0) | ||
| 15 | 30/35 (85.71) | 0/30 (0) | NT | ||
| R-15041170 | 7 | 2 | 25/25 (100) | 25/25 (100) | NT |
| 6 | 30/30 (100) | 30/30 (100) | 1/30 (3.33) | ||
| 15 | 30/30 (100) | 30/30 (100) | 11/30 (36.67) | ||
| 4.7 | 2 | 24/25 (96) | 11/24 (45.83) | NT | |
| 6 | 30/30 (100) | 29/30 (96.67) | 0/29 (0) | ||
| 15 | 25/27 (92.59) | 23/25 (92) | 1/23 (4.34) | ||
| R-15060131 | 7.4 | 2 | 25/25 (100) | 25/25 (100) | NT |
| 6 | 30/30 (100) | 30/30 (100) | 2/30 (6.67) | ||
| 15 | 21/21 (100) | 21/21 (100) | 4/21 (19.05) | ||
| 4.1 | 2 | 25/25 (100) | 17/25 (68) | NT | |
| 6 | 30/30 (100) | 28/30 (93.33) | 1/28 (3.57) | ||
| 15 | 29/30 (96.67) | 26/29 (89.66) | 2/26 (7.69) |
*L1, lineage 1; L2, lineage 2; NT, not tested; R, reassortant (containing lineage 1 large RNA segment and lineage 2 small and medium RNA segments); NT, not tested. †p<0.05: lineage 1 strains dissemination rate compared with lineage 2 strains when mosquito fed on infectious blood ≈6.3–7.4 log10 PFU/mL titer. ‡p<0.05: lineage 1 strain infection rate compared with lineage 2 strains when mosquito fed on infectious blood ≈6.3–7.4 log10 PFU/mL titer.